Stock Screener

Show:
Sort
Country
Sector
Risk rating
1
2
3
4
5
6
7
Risk factors

    Default risk

    1
    2
    3
    4
    5
    6
    7

    Volatility

    1
    2
    3
    4
    5
    6
    7

    Stress test

    1
    2
    3
    4
    5
    6
    7

    Selling difficulty

    1
    2
    3
    4
    5
    6
    7

    Country risks

    1
    2
    3
    4
    5
    6
    7

    Other risks

    1
    2
    3
    4
    5
    6
    7
Profitability factors

    Valuation

    1
    2
    3
    4
    5
    6
    7

    Analyst view

    1
    2
    3
    4
    5
    6
    7

    Performance

    1
    2
    3
    4
    5
    6
    7

    Profitability

    1
    2
    3
    4
    5
    6
    7

    Growth

    1
    2
    3
    4
    5
    6
    7

    Dividends

    1
    2
    3
    4
    5
    6
    7
Results: 89

AstraZeneca PLC

AZN
5

GSK plc

GSK.L
6

Roivant Sciences Ltd.

ROIV
3

Haleon plc

HLN.L
6

LivaNova PLC

LIVN
4

Smith & Nephew plc

SNN
6

Kiniksa Pharmaceuticals International, plc

KNSA
4

Convatec Group PLC

CTEC.L
5

Hikma Pharmaceuticals PLC

HIK.L
6

COMPASS Pathways plc

CMPS
3

Immunocore Holdings plc

IMCR
3

CVS Group plc

CVSG.L
5

Genus plc

GNS.L
5

Mereo BioPharma Group plc

MREO
2

Spire Healthcare Group plc

SPI.L
5

Craneware plc

CRW.L
5

Oxford Biomedica plc

OXB.L
2

Autolus Therapeutics plc

AUTL
2

Oxford Nanopore Technologies plc

ONT.L
3

Bicycle Therapeutics plc

BCYC
3

Advanced Medical Solutions Group plc

AMS.L
4

Silence Therapeutics plc

SLN
2

Tristel PLC

TSTL.L
5

Animalcare Group plc

ANCR.L
3

OKYO Pharma Limited

OKYO
3

SkinBioTherapeutics Plc

SBTX.L
2

Biodexa Pharmaceuticals Plc

BDRX
3

Hemogenyx Pharmaceuticals Plc

HEMO.L
2

Optima Health plc

OPT.L
3

ImmuPharma plc

IMM.L
2

hVIVO plc

HVO.L
3

Tiziana Life Sciences Ltd

TLSA
3

Shield Therapeutics plc

STX.L
3

Venture Life Group plc

VLG.L
4

INSPECS Group plc

SPEC.L
3

Scancell Holdings plc

SCLP.L
2

Diaceutics PLC

DXRX.L
3

Bioventix PLC

BVXP.L
4

NuCana plc

NCNA
3

Creo Medical Group PLC

CREO.L
2

Nuformix plc

NFX.L
1

EKF Diagnostics Holdings plc

EKF.L
3

Kooth plc

KOO.L
5

Fusion Antibodies plc

FAB.L
1

ECO Animal Health Group plc

EAH.L
4

GENinCode Plc

GENI.L
3

genedrive plc

GDR.L
1

Virax Biolabs Group Limited

VRAX
3

Oxford BioDynamics Plc

OBD.L
3

Aptamer Group PLC

APTA.L
2

Genflow Biosciences plc

GENF.L
1

Provexis plc

PXS.L
1

Sareum Holdings plc

SAR.L
3

Inspiration Healthcare Group plc

IHC.L
3

OptiBiotix Health Plc

OPTI.L
2

Physiomics Plc

PYC.L
3

Allergy Therapeutics plc

AGY.L
1

Physitrack PLC

PTRK.ST
3

OptiBiotix Health PLC

OPTBF
2

RUA Life Sciences plc

RUA.L
3

ValiRx plc

VAL.L
2

CelLBxHealth plc

AGL.L
3

BSF Enterprise Plc

BSFA.L
3

Feedback plc

FDBK.L
3

Arecor Therapeutics plc

AREC.L
1

Cambridge Cognition Holdings Plc

COG.L
2

Abingdon Health Plc

ABDX.L
2

Cizzle Biotechnology Holdings Plc

CIZ.L
3

NIOX Group Plc

CSSPF
3

4basebio PLC

4BB.L
3

IXICO plc

IXI.L
3

Proteome Sciences plc

PRM.L
2

Doctor Care Anywhere Group PLC

DOC.AX
3

Verici Dx plc

VRCI.L
3

Theracryf Plc

TCF.L
3

Cambridge Nutritional Sciences plc

CNSL.L
3

Avacta Group Plc

AVCTF
1

Surgical Innovations Group plc

SUN.L
3

Futura Medical plc

FAMDF
3

Rafina Innovations Inc.

VICA
3

Poolbeg Pharma PLC

POLBF
2

Alterola Biotech, Inc.

ABTI
3

Lombard Medical, Inc.

EVARF

Chill Brands Group PLC

CHBRF
1

Adaptimmune Therapeutics plc

ADAP
3

ReNeuron Group plc

RENE.L
1

Benchmark Holdings plc

BMK.L
3

Deltex Medical Group plc

DEMG.L
2

Synairgen plc

SNG.L
3
Guru Portfolios

Track the investments of top funds and market legends

Charlie Munger (1924-2023)

Charlie Munger (1924-2023)

Daily Journal Corp

Return for Q2 2026:6.65%

Portfolio composition:

+2 Holdings
Stephen Mandel

Stephen Mandel

Lone Pine Capital

Return for Q2 2026:14.99%

Portfolio composition:

+32 Holdings
Go to section